Endothelin-1 in the exhaled breath condensate of patients with non-specific interstitial pneumonia (NSIP) and of patients with fibrosing alveolitis associated with systemic sclerosis (FASSc) Source: Eur Respir J 2002; 20: Suppl. 38, 226s Year: 2002
Parameters of antioxidant protection in patients with cryptogenic fibrosing alveolitis Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007
Induced sputum neutrophilia and increased neurotrophin levels in patients with cryptogenic fibrosing alveolitis Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002
Sputum eosinophilia in cryptogenic fibrosing alveolitis Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003
The study of C5a complement component in patients with idiopathic pulmonary fibrosis, toxic fibrosing alveolitis and extrinsic allergic alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001
Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002
Lung cancer in patients with cryptogenic fibrosing alveolitis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008
Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008
Analysis of IL-13 polymorphisms in patients with cryptogenic fibrosing alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 411s Year: 2001
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: 43S-55S Year: 2001
Macrophage derived inflammatory mediators and thoracic HRCT scoring in scleroderma fibrosing alveolitis Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
Induced sputum MMPs in scleroderma fibrosing alveolitis Source: Eur Respir J 2006; 28: Suppl. 50, 830s Year: 2006
Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016
The features of the course of cryptogenic fibrosing alveolitis in women Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002
Serum chitotriosidase levels in granulomatous lung disorders Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006
Plasma fibronectin as the criterion of idiopathic fibrosing alveolitis severity Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Cytokine regulation in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis: clinicomorphological study Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001
Cytokine gene polymorphisms in fibrosing alveolitis in rheumatoid arthritis and idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 1s Year: 2001
Elevated exhaled and circulatory markers of oxidative stress in patients with systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002
Specific features of the course of cryptogenic fibrosing alveolitis in pregnancy Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001